I've been following CoreWeave (CRWV), a cloud infrastructure company focused on high-performance computing for AI workloads. They offer the CoreWeave Cloud Platform, which includes proprietary software and services to manage large-scale AI infrastructure—think GPU compute, CPU compute, networking, and storage tailored for machine learning, visual effects rendering, and batch processing.
Their model centers on renting access to Nvidia graphics processing units (GPUs) and other AI hardware, letting customers scale AI training and inference without the hassle of building data centers themselves. In the crowded cloud computing space, CoreWeave stands out as a specialized "neocloud" provider aimed at AI hyperscalers and developers amid booming compute demand. From what I see, their $66.8 billion contracted backlog and priority access to next-gen Nvidia chips through key partnerships provide solid revenue visibility, which has clearly supported the recent stock strength.
In the past 30 days, CRWV stock rose +58%, moving from around $81 to $128. The uptrend was volatile but directionally strong, with sharp moves after major announcements like multi-billion-dollar deals and analyst upgrades. Shares pushed higher from mid-April lows near $105, gaining speed in late April and early May on positive AI sentiment.
Looking at the quarter, the stock gained +42%, from about $90 to $128. It started range-bound with a dip to $73 in early March, then recovered on financing and contract news. Overall, it showed solid upward momentum, beating broader tech indices despite volatility linked to AI hype.
The +58% move over 30 days came from company-specific news affirming CoreWeave's leadership in AI cloud. A standout was the April 9 expansion of its deal with Meta Platforms to $21 billion through 2032, adding dedicated AI inference capacity and early access to Nvidia's Vera Rubin GPUs. This built on earlier agreements and strengthened hyperscaler relationships, giving investors confidence in sustained demand.
Other deals included a multi-year agreement with Anthropic for Claude AI models and a $6 billion pact with Jane Street, with $1 billion in equity. These boosted the $66.8 billion backlog, pointing to faster revenue from AI training and deployment. I also checked this using Tickeron’s AI Screener to compare how CRWV stacks up against industry peers.
Analysts piled on, with Jefferies lifting its target to $160 (Buy), Citigroup to $155 (Buy), Oppenheimer to $150 (Outperform), and Wells Fargo to $135 (Overweight) in late April. These reflected AI demand outstripping supply, amplified by $700 billion hyperscaler capex expectations.
The quarter's +42% advance rode broader AI infrastructure momentum, rebounding from February lows. A major factor was the $8.5 billion GPU-backed loan in March, funding capacity growth and securing investment-grade status thanks to contracts like Meta's. This fit into $28 billion raised over 12 months to meet capex demands amid GPU shortages.
Q4 2025 results delivered revenue doubling to $1.57 billion, full-year growth to $5.13 billion, and a tripling backlog. Nvidia partnerships for chip priority enhanced their edge over hyperscalers. Macro tailwinds like AI capex growth and steady GPU pricing kept things moving, even with high debt and margin pressures from $30 billion+ FY26 capex plans. Institutional buying, including Cathie Wood's stake after a 78% YTD run, underscored investor interest.
In my research, I often turn to Tickeron’s Trending AI Robots page, which highlights the platform's top-performing AI trading bots out of hundreds. These bots analyze and trade thousands of tickers across markets using strategies like trend-following, mean reversion, or momentum, from intraday to long-term plays. They display key metrics—win rate, profit factor, Sharpe ratio—and update in real-time based on recent performance. It's a practical way to find bots suited to current conditions and your risk profile, powered by machine learning for better trading outcomes.
One thing I'm watching closely is the Q1 2026 earnings on May 7, expected to show $1.96 billion in revenue (+100% YoY), backlog progress, and margins heading toward low double-digits by year-end. Capacity rollouts, like 1.7 GW of power coming online, will gauge execution against $30-35 billion capex.
Keep an eye on Nvidia GPU supply, rival ASIC shifts that could pressure pricing, and macro factors like interest rates on $14.7 billion long-term debt. AI capex from hyperscalers such as META and Microsoft remains crucial. New partnerships, potential OpenAI deals, execution risks, competition, debt handling, and improving free cash flow will all influence the path ahead. In my view, this is important because it tests whether the momentum can sustain.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
CRWV saw its Momentum Indicator move above the 0 level on May 01, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 12 similar instances where the indicator turned positive. In of the 12 cases, the stock moved higher in the following days. The odds of a move higher are at .
The Moving Average Convergence Divergence (MACD) for CRWV just turned positive on May 04, 2026. Looking at past instances where CRWV's MACD turned positive, the stock continued to rise in of 8 cases over the following month. The odds of a continued upward trend are .
CRWV moved above its 50-day moving average on April 08, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for CRWV crossed bullishly above the 50-day moving average on April 13, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 2 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where CRWV advanced for three days, in of 62 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 55 cases where CRWV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for CRWV moved out of overbought territory on May 07, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 8 similar instances where the indicator moved out of overbought territory. In of the 8 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRWV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
CRWV broke above its upper Bollinger Band on May 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CRWV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (20.408) is normal, around the industry mean (13.840). P/E Ratio (0.000) is within average values for comparable stocks, (129.371). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.508). CRWV has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.028). P/S Ratio (10.953) is also within normal values, averaging (153.501).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRWV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows